Insights Corner

NASDAQ: ABVC

Insights Corner

A Natural Approach to Alleviate Depression in Cancer Patients with Dr. Scott Irwin

 A Natural Approach to Alleviate Depression in Cancer Patients with Dr. Scott Irwin 1858 976 ABVC
  • ABVC

https://www.youtube.com/watch?v=QZ754OpWC7E In this video we talk wit Dr. Scott Irwin from Cedar-Sinai Medical Center. He shares insights on how we use a natural and herbal way to treat Depression in Cancer Patients. Scott A. Irwin, MD, PhD, FCLP, FAPA is professor of Psychiatry. He is currently the Director of the Patient and Family Support Program at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute. His pioneering work involves exploring the potential of natural and herbal remedies in addressing the complex emotional challenges faced by individuals battling cancer. In this video he talks about his work with ABVC during the Phase I Clinical…

|ABVC BioPharma on McNallie Money | Best Biopharmaceutical Stocks Now

 |ABVC BioPharma on McNallie Money | Best Biopharmaceutical Stocks Now 150 150 Russ Jaimes

https://www.youtube.com/watch?v=LbyWDe2wmW4& Have you seen this? ABVC has been featured in a recent video on McNallie Money. In this video, McNallie dives deep into our website and our pitch deck. We’re excited to see others recognizing the work of our doctors and scientist. It was great reading some positive comments on the video: @gilbertapicella2652 – It’s great to see ABVC BioPharma’s dedication to tackling various diseases and conditions through their extensive pipeline.- @jacentaschwartzbach5246 – ABVC BioPharma seems to be at the forefront of developing innovative solutions to address unmet medical needs. Exciting times ahead! @shawnlocke8904 – Interesting and creative approach by…

What is Major Depressive Disorder (MDD)

 What is Major Depressive Disorder (MDD) 1920 1280 ABVC

What is Major Depressive Disorder (MDD) Major Depressive Disorder (MDD), also known as clinical depression, is a mental health condition characterized by persistent and severe symptoms that can significantly impact a person’s daily life. Living with Major Depressive Disorder (MDD) can be an overwhelming and challenging experience. Each day can feel like an uphill battle, as even the simplest tasks can become monumental struggles. It can often make it difficult to find joy or interest in things that used to bring happiness. Identifying MDD MDD can come in several forms, and symptoms can vary in severity and duration from person…

Meet The CEO of ABVC

 Meet The CEO of ABVC 0 0 ABVC

https://youtu.be/Kxbs–OfdVA?si=ajlAoLB2RIkP1swV Join us as we speak with the CEO of ABVC, Dr. Uttam Yashwant Patil, as he talks about the future of the company.

Dealing with Adult ADHD

 Dealing with Adult ADHD 1640 924 ABVC

ADHD, or Attention-Deficit/Hyperactivity Disorder, is a neurodevelopmental disorder that can affect both children and adults. Persistent inattention, impulsivity, and hyperactivity patterns that characterize it can impact daily life. Individuals with ADHD often struggle with maintaining focus, following through on tasks, organizing activities, and controlling impulses.

ADHD can lead to challenges in academic, occupational, and social settings. While ADHD is a neurological condition, its exact causes are not fully understood and possibly result from genetic, environmental, and brain-related factors. Proper diagnosis and management of ADHD typically involve a comprehensive assessment by medical professionals, behavioral interventions, counseling, and in some cases, medication to help individuals effectively navigate the cognitive and behavioral challenges associated with the disorder.

NEW: Summer 2023 Investor Presentation

View the latest product information, status updates, financial information, and more.

VIEW PRESENTATION
PRESS RELEASES
CONTACT ABVC
SAFE HARBOR STATEMENT

With the exception of historical information, the matters discussed in this presentation are forward-looking statements that involve a number of risks and uncertainties. The actual future results of ABVC could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company’s operations, inability to hire and retain qualified personnel, and changes in the general economic climate. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” or “continue,” the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by ABVC, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. This release does not constitute an offer to sell or a solicitation of offers to buy any securities of any entity.

Investor Considerations

  • Strong portfolio of medicines and medical devices addresses wide range of disorders.
  • In 2022, Vitargus is expected to begin a global pivotal trial, the final step leading to marketing in collaboration with big pharma licensing partners.
  • MDD drug intended to reduce adult depression completes Clinical Phase II with results exceeding expectations.
  • Botanical expertise leads to medicines with fewer side effects.
  • Partnerships with some of the most prestigious researchers in the world enhances the value of clinical trial results.
  • Business model designed to minimize burn rate.
  • Less than 30 million shares outstanding.

BACKGROUND

Leadership Team

MANAGEMENT
ADVISORY

NASDAQ: ABVC

Latest News

ABVC NEWSROOM

THERAPEUTIC FOCUS

Retinal Vitrectomy

Vitargus® – ABV-1701
Contact ABVC & Stay Informed

Contact ABVC BioPharma

SOCIAL MEDIA

Facebook

LinkedIn

TELEPHONE

+1 845-291-1291

EMAIL

info@abvcpharma.com

44370 Old Warm Springs Boulevard
Fremont, California 94538 USA
CONTACT FORM

Copyright ©2023 ABVC BioPharma, Inc. All Rights Reserved.

   

Enter your
search terms here.